Frontiers in Genetics (Apr 2023)

Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing

  • Yu-Fang Tang,
  • Yu-Fang Tang,
  • Yu-Fang Tang,
  • Yu-Fang Tang,
  • Pu-Gen An,
  • Pu-Gen An,
  • Pu-Gen An,
  • Bao-Xin Gu,
  • Bao-Xin Gu,
  • Bao-Xin Gu,
  • Shu Yi,
  • Shu Yi,
  • Shu Yi,
  • Xiao Hu,
  • Xiao Hu,
  • Xiao Hu,
  • Wen-Jie Wu,
  • Wen-Jie Wu,
  • Wen-Jie Wu,
  • Jie Zhang,
  • Jie Zhang,
  • Jie Zhang

DOI
https://doi.org/10.3389/fgene.2023.1144945
Journal volume & issue
Vol. 14

Abstract

Read online

Background: The aim of this study was to investigate the underlying mechanisms of adenoid cystic carcinoma (ACC) at the transcriptome level.Materials and methods: We obtained paired tumor and normal salivary gland tissues from 15 ACC patients, which were prepared for RNA sequencing.Results: Gene enrichment analysis revealed that the upregulated pathways were mainly involved in axonogenesis, and the downregulated pathways were mainly related to leukocyte migration, the adaptive immune response, lymphocyte-mediated immunity, and the humoral immune response. T-cells, B-cells and NK cells showed low infiltration in ACC tissues. In addition to the gene fusions MYB-NFIB and MYBL1-NFIB, a new gene fusion, TVP23C-CDRT4, was also detected in 3 ACC tissues. PRAME was significantly upregulated in ACC tissues, while antigen-presenting human leukocyte antigen (HLA) genes were downregulated.Conclusion: We found a new gene fusion, TVP23C-CDRT4, that was highly expressed in ACC. PRAME may be an attractive target for ACC immunotherapy.

Keywords